In recent years, LINC‐PINT presents tumor inhibitory potential in many cancers.14, 15 For instance, LINC‐PINT can inhibit pancreatic ductal adenocarcinoma by activating TGF‐β signaling.16 LINC‐PINT can activate the MAPK signaling to induce acute myocardial infarction via sponging miR‐208a‐3p.17 However, whether LINC‐PINT affects the biological behavior of NSCLC cells through regulating miRNAs remains undetermined. The gene discussed is LINC-PINT; the disease is myocardial infarction.